FitLife Brands, Inc. (FTLF) develops and markets its own line of nutritional supplements and wellness items targeted at health-focused buyers, mainly in the United States with some international reach. The lineup covers weight-loss aids, sports nutrition, general wellness, energy items, and natural skincare. I follow the name because it functions as a multi-brand platform in a fragmented yet expanding dietary-supplement sector, backed by a mix of retail, franchise, and direct online sales channels.
FitLife Brands dates back to its incorporation in 2005, originally under the name Bond Laboratories, Inc., before the current name took hold in September 2013. It is based in Omaha, Nebraska, with shares trading on the Nasdaq Capital Market under FTLF. Dayton Judd leads as Chairman and Chief Executive Officer.
At heart, FitLife acts more as a brand manager than a traditional manufacturer. It creates and promotes finished nutritional products sold through varied channels. The approach revolves around buying, integrating, and growing supplement brands before moving them across retail, franchise, wholesale, and online outlets.
The portfolio breaks into brand groups. NDS Products covers NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition. iSatori Products includes iSatori, BioGenetic Laboratories, and Energize. MRC Products, added via the 2023 Mimi's Rock Corp. deal, features Dr. Tobias, All Natural Advice, and Maritime Naturals. MusclePharm joined in 2023, while the Irwin Products group (Irwin Naturals, Applied Nutrition, and Nature's Secret) arrived in August 2025. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Revenue comes primarily from finished nutritional supplements and wellness goods. Sales routes differ by brand: NDS items move largely through GNC franchise and corporate spots, iSatori through specialty and mass retailers plus online, MRC mainly via e-commerce like Amazon, and MusclePharm along with Irwin through a blend of wholesale, mass-market, and online. Online sales, especially on Amazon's U.S. site, have formed a sizable part of net revenue lately, though wholesale and retail ties have widened with deals like Irwin Naturals.
FitLife competes in a crowded space with larger supplement and consumer-health players. Its position remains that of a smaller, acquisition-led consolidator, relying on brand strength, product formulas, and distribution ties rather than sheer manufacturing volume.
Attention centers on FitLife's role as a consolidator in the supplement space. Acquisitions such as Mimi's Rock Corp., MusclePharm, and Irwin Naturals have broadened the brand set and spread revenue across channels and categories. This buy-and-integrate approach forms a core part of its longer-term growth narrative.
Broader industry trends help as well. Greater consumer focus on health, wellness, and preventive nutrition, plus an aging population in key markets, underpins demand for dietary supplements. The multi-channel setup across franchise retail, mass stores, and Amazon e-commerce spreads exposure and lessens reliance on any one outlet.
Financially, FitLife is a small-cap name with modest staff and revenue compared to major packaged-food and supplement firms. Its profile reflects an acquisition strategy that has lifted revenue in recent years, though it also carries associated debt. From what I see, many investors assess the company on how well it folds in new brands and turns the expanded portfolio into steady profits. When reviewing peers, I sometimes turn to Tickeron’s AI Trend Prediction Engine for added context on sector movements.
Several risks warrant attention. The dietary-supplement field is competitive and straightforward to enter, with ongoing pressure from established names and private-label options. Customer and channel concentration stands out too: Amazon has driven a large share of sales recently, and key retail ties cluster among a few national players. Shifts in platform fees, algorithms, or buyer habits could influence outcomes.
Acquisition risk matters as well. Growth hinges on smooth integration of bought brands, and debt has funded moves like the Irwin Naturals purchase, partly through a term loan and revolving credit facility. Higher leverage and integration expenses could weigh on margins. The category also faces regulatory oversight, changing labeling rules, and sensitivity around product quality that can sway demand and costs.
FitLife Brands stands as a compact, acquisition-driven participant in nutritional supplements, having built a varied brand collection across weight loss, sports nutrition, wellness, and skincare. Its combination of franchise retail, mass wholesale, and Amazon-focused e-commerce sets it apart from single-channel sellers, while the buy-and-integrate tactic shapes both upside potential and financial exposure. For those tracking the consumer-health area, FitLife provides a targeted lens on a consolidator operating where wellness trends, retail channels, and brand oversight meet.
In my own research on names like FTLF, I often rely on Tickeron’s AI Screener to quickly filter stocks by technical indicators, fundamentals, and industry patterns. It helps surface comparable ideas without sifting through thousands of results manually, keeping my watchlist focused and efficient.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
FTLF saw its Momentum Indicator move below the 0 level on November 16, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 98 similar instances where the indicator turned negative. In 78 of the 98 cases, the stock moved further down in the following days. The odds of a decline are at 80%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 48 cases where FTLF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 73%.
The Moving Average Convergence Divergence Histogram (MACD) for FTLF turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 38 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 75%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FTLF declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
The Aroon Indicator for FTLF entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for FTLF's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
Following a +3.04% 3-day Advance, the price is estimated to grow further. Considering data from situations where FTLF advanced for three days, in 140 of 211 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
FTLF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Valuation Rating of 55 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.580) is normal, around the industry mean (6.914). P/E Ratio (11.896) is within average values for comparable stocks, (7.137). Projected Growth (PEG Ratio) (0.010) is also within normal values, averaging (8.458). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.922) is also within normal values, averaging (5.003).
The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 74 (best 1 - 100 worst), indicating slightly worse than average price growth. FTLF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FTLF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry FoodMajorDiversified